FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 5.035
AS - Asia 2.789
EU - Europa 1.440
SA - Sud America 487
AF - Africa 48
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.809
Nazione #
US - Stati Uniti d'America 4.922
SG - Singapore 1.088
CN - Cina 850
BR - Brasile 419
UA - Ucraina 310
DE - Germania 308
HK - Hong Kong 279
TR - Turchia 195
VN - Vietnam 167
GB - Regno Unito 160
IT - Italia 158
FI - Finlandia 108
SE - Svezia 108
RU - Federazione Russa 90
ID - Indonesia 58
MX - Messico 58
PL - Polonia 46
CA - Canada 44
IN - India 37
AT - Austria 27
AR - Argentina 26
BD - Bangladesh 26
ZA - Sudafrica 25
FR - Francia 24
ES - Italia 20
NL - Olanda 16
CZ - Repubblica Ceca 14
JP - Giappone 14
LT - Lituania 14
EC - Ecuador 13
IQ - Iraq 12
KE - Kenya 8
VE - Venezuela 8
AU - Australia 7
BE - Belgio 7
KR - Corea 7
CL - Cile 6
MA - Marocco 6
TW - Taiwan 6
CH - Svizzera 5
IL - Israele 5
IR - Iran 5
PY - Paraguay 5
RO - Romania 5
IE - Irlanda 4
JO - Giordania 4
KZ - Kazakistan 4
PK - Pakistan 4
PT - Portogallo 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
GT - Guatemala 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
CO - Colombia 2
DK - Danimarca 2
JM - Giamaica 2
LB - Libano 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
TT - Trinidad e Tobago 1
UG - Uganda 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.809
Città #
Singapore 627
Ashburn 481
Fairfield 473
Woodbridge 437
Santa Clara 317
Jacksonville 303
Beijing 280
Hong Kong 277
Houston 277
Chandler 267
Ann Arbor 189
Wilmington 176
Cambridge 172
Seattle 157
Los Angeles 137
Izmir 129
Nanjing 99
Princeton 92
Munich 83
New York 69
Dallas 62
Ho Chi Minh City 62
Buffalo 53
Jakarta 49
Shanghai 47
São Paulo 45
Mexico City 43
Milan 43
Warsaw 41
Council Bluffs 39
San Diego 38
Boardman 36
Addison 35
Hefei 35
Tianjin 34
Hebei 31
Nanchang 29
Turku 27
Hanoi 26
Helsinki 25
Shenyang 25
Changsha 24
Jiaxing 23
Bremen 21
London 21
Dong Ket 20
Rio de Janeiro 20
Vienna 20
Chicago 18
San Mateo 18
Moscow 17
Chennai 16
Norwalk 16
Nuremberg 16
Denver 15
Boston 14
Brooklyn 14
Johannesburg 14
Montreal 14
Falkenstein 13
Phoenix 13
Tokyo 13
Washington 13
Atlanta 12
Brasília 12
Dearborn 12
Toronto 12
Frankfurt am Main 11
Guangzhou 11
Orem 11
Redwood City 11
San Francisco 11
Belo Horizonte 10
Brno 10
Ferrara 10
Ningbo 10
Jinan 9
Mountain View 9
Philadelphia 9
Poplar 9
Taizhou 9
Ankara 8
Campinas 8
Falls Church 8
Hangzhou 8
Nairobi 8
Porto Alegre 8
Zhengzhou 8
Baghdad 7
Brussels 7
Charlotte 7
Curitiba 7
Da Nang 7
Genoa 7
Haiphong 7
Krasnodar 7
Manchester 7
Monmouth Junction 7
Secaucus 7
Fortaleza 6
Totale 6.567
Nome #
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 206
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 200
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 198
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 194
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 177
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 168
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 167
Airway smooth muscle biochemistry and asthma 162
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 162
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 161
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 161
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 160
Enfisema polmonare: prospettive di terapia 159
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 155
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 155
Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement 154
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 154
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 150
Helicobacter pylori and chronic bronchitis 148
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 143
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 142
Asthma progression and mortality: The role of inhaled corticosteroids 142
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 137
Anti-inflammatory treatments for asthma: Past, present, future 135
Altri problemi di patologia respiratoria 135
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 133
Inhaled corticosteroids in COPD: Friend or foe? 133
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 131
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 130
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 130
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 130
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 128
Blood eosinophils for the management of COPD patients? 128
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 127
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 126
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 122
Inhaled corticosteroid containing combinations and mortality in COPD 121
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 120
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 117
What can we learn from late-onset and occupational asthma? 116
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 116
Prevention of Chronic Obstructive Pulmonary Disease 114
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 112
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 110
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 110
Severity of airflow limitation is associated with severity of airway inflammation in smokers 110
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 109
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 109
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 108
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 108
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 106
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 102
Neutrophils and Asthma 101
Mechanism of occupational asthma 100
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 100
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 100
Neutrophils and asthma. 99
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 99
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 99
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 98
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 97
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 94
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 94
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 92
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 92
Management of chronic refractory cough in adults 91
Chronic cough in adults 90
Glucocorticoidi 89
HLA class II molecules and asthma induced by toleune diisocyanate 89
Guidelines and recommendations for the clinical use of bronchoalveolar lavage in asthma 88
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 84
Evaluation by self-monitoring and noninvasive measures 78
Small airway dysfunction: not so silent after all? 78
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 76
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 75
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 70
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 66
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 63
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 52
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 51
null 50
Rate of Decline of FEV1 as Biomarker of Survival? 49
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 48
null 45
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 40
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 39
A person-centred clinical approach to the multimorbid patient with COPD 38
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study 10
Totale 9.955
Categoria #
all - tutte 53.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.566
Totale 54.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021620 0 0 0 0 0 75 30 106 27 109 148 125
2021/2022797 28 53 49 61 61 25 25 46 36 55 71 287
2022/2023646 78 16 40 79 115 86 36 59 74 3 41 19
2023/2024391 42 48 20 15 25 54 13 25 15 5 11 118
2024/20251.796 38 59 155 47 238 161 29 61 282 224 272 230
2025/20262.767 568 223 437 662 794 83 0 0 0 0 0 0
Totale 9.955